dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Maybe competition is good for what 'ails' hospitals Mergers may be good for business, but what about patients?

Frost & Sullivan outline 10 growth factors for precision imaging market Market predicted to be more than $8 billion by 2027

RadNet buys Kern Radiology The Bakersfield, California imaging group includes four offices

More of GE healthcare unit could be on block: CEO CEO Culp speaks in post-earnings call after company exceeds Q4 expectations

Philips, Lunit, Vuno in healthcare AI deal Forging partnerships to advance AI applications

Trade war forcing Philips to move production between US, China CEO van Houten addresses company growth in earnings call

Aetna, Anthem, Health Care Service, PNC Bank and IBM collaborate on healthcare blockchain 'ecosystem' Increasing industry transparency

Clinical wearables – remaining competitive in an evolving market Insights from Ravi Kuppuraj, Business Leader of Connected Sensing Venture for Philips

Mass General plans $1 billion new building Adding a 12-story building with 450 single-bed rooms

iSchemaView, NeuroLogica partner for stroke care Bringing the RAPID platform to the portable CereTom CT

CMS denies reimbursement for sodium fluoride PET scans

by Lisa Chamoff , Contributing Reporter
In a final decision memo released Dec. 15, CMS said it had determined that use of an NaF-18 PET scan to identify bone metastasis of cancer “is not reasonable and necessary to diagnose or treat an illness or injury or to improve the functioning of a malformed body member.”

The agency said it is awaiting evidence, published in a peer-reviewed journal, showing that NaF-18 PET imaging leads to a change in patient management to more appropriate palliative care, a change in patient management to more appropriate curative care, improved quality of life or improved survival. CMS will continue reimbursing for NaF-18 PET under coverage with evidence development (CED) programs for 24 months following the announcement of the decision.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



Dr. Barry Siegel, co-chair of the working group for the National Oncologic PET Registry, which has collected information on how doctors have used the scans to make decisions about patient care, said he was disappointed, though not surprised, by the decision.

“We are considering our options with respect to any additional data that we can bring to help change CMS’s decision,” Siegel, who also serves as a professor of radiology and medicine and the director of nuclear medicine at Washington University in St. Louis, told HCB News.

Siegel said the data that was collected showed that at least 30 percent of the time, the approach doctors said they were going to take before the scan was different from what they decided to do after the scan, though the studies had no control group.

“We don’t know whether doing a conventional bone scan would have led to the same outcome,” Siegel said. “Medicare knew that going in. We did what we said we were going to do with the protocol they approved.”

The data collected for NaF-18 PET was similar to the data collected on oncologic uses of FDG-PET, Siegel said. CMS removed the CED requirement for FDG-PET in 2013.

“We have ideas about what we can do,” Siegel said. “We don’t know if it’s enough to satisfy CMS.”

Dr. Gary Dillehay, past president of the Society of Nuclear Medicine and Molecular Imaging and professor of radiology at Northwestern University's Feinberg School of Medicine, said CMS is taking a closer look at new technology.

“Unfortunately, everything new in nuclear medicine has been expensive compared to what’s out there,” Dillehay told HCB News. “Being just as good as, or a little bit better, than the current technique is not going to work with CMS anymore.”

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED